BSD Medical Obtains Marketing Approval in Russian Federation for Hyperthermia Systems
BSD Medical Corporation (NASDAQ: BSDM) announced today that the Company has obtained approval to market its hyperthermia systems in the Russian Federation. The Company's hyperthermia products will be marketed in Russia by MSM-Medimpex (Medimpex), a premier distributor of sophisticated oncology medical devices in Russia. Medimpex also distributes radiation therapy devices from Electa, which dominate the oncology market in Russia. The marketing approval covers all BSD-2000 Hyperthermia System configurations and the BSD-500 Hyperthermia System.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.